Dynorphin opioid inhibition of cocaine‐induced, D1 dopamine receptor‐mediated immediatem‐early gene expression in the striatum
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Neurons in the striatum that project to the substantia nigra contain the opioid peptide dynorphin. Stimulation of D1 dopamine receptors results in increased expression of mRNA encoding dynorphin as well as expression of immediate‐early genes such as c‐fos in these neurons. Levels of dynorphin vary in different regions of the normal rat striatum, being highest in ventral and medial striatum. In a prior study, we have shown that both regional and temporal patterns of c‐fos induction following treatment with the indirect dopamine receptor agonist cocaine are inversely related to those of dynorphin expression. These results suggested that dynorphin is involved in regulating the responsiveness of these neurons to dopamine input. In the present experiments, we examined such a potential role for dynorphin by analyzing the influence of the dynorphin (kappa opioid receptor) agonist spiradoline on immediate‐early gene induction by cocaine, and we determined that this immediate‐early gene response is mediated by D1 dopamine receptors located in the striatum. As a marker of neuron activation, expression of c‐fos and zif 268 immediate‐early genes was assessed with quantitative in situ hybridization histochemistry. Results showed that (1) intrastriatal infusion of the D1 dopamine receptor antagonist SCH‐23390 (2.5–250 pmol) resulted in a dose‐dependent blockade of immediate‐early gene induction by cocaine (30 mg/kg); (2) systemic administration of the kappa opioid receptor agonist spiradoline (0.5–10.0 mg/kg) decreased cocaine‐induced expression of c‐fos and zif 268 mRNAs in striatum in a dose‐dependent manner; (3) intrastriatal infusion of spiradoline (1–50 nmol) also suppressed immediate‐early gene induction by cocaine, demonstrating that kappa opioid receptors located in the striatum mediate such an effect; and (4) systemic and intrastriatal administration of spiradoline also affected immediate‐early gene expression in cortex. These results demonstrate that, in striatum, immediate‐early gene induction by cocaine is a D1 dopamine receptor‐mediated process that is inhibited by activation of kappa opioid receptors. Therefore, these findings suggest that the striatal dynorphin opioid system acts directly and/or indirectly to inhibit dopamine input to striatonigral neurons through kappa opioid receptor‐mediated processes in the striatum. © 1995 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Self-citationStimulus-transcription coupling in neurons: role of cellular immediate-early genes
Morgan, J. I., & Curran, T. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90096-9 · Cited by 969
Gerfen, C. R., & Scott Young, W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91217-6 · Cited by 658
Self-citationCocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
Sivam, S. P. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22808-7 · Cited by 167
Characterization of methamphetamine effects on the striatal-nigral dynorphin system
Hanson, G. R., Merchant, K. M., Letter, A. A., Bush, L., & Gibb, J. W. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90397-4 · Cited by 77
Cited by
Herdegen, T., & Leah, J. D. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00018-6 · Cited by 1,350
Regulation of cocaine reward by CREB
Carlezon, W. A., Thome, J., Olson, V. G., Lane-Ladd, S. B., Brodkin, E. S., Hiroi, N., Duman, R. S., Neve, R. L., & Nestler, E. J. (1998) · Science · doi:10.1126/science.282.5397.2272 · Cited by 767
O'Donovan, K. J., Tourtellotte, W. G., Millbrandt, J., & Baraban, J. M. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01343-5 · Cited by 457
Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior
Steiner, H., & Gerfen, C. R. (1998) · Experimental Brain Research · doi:10.1007/s002210050545 · Cited by 365
Self-citationA Complex Program of Striatal Gene Expression Induced by Dopaminergic Stimulation
Berke, J. D., Paletzki, R. F., Aronson, G. J., Hyman, S. E., & Gerfen, C. R. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05301.1998 · Cited by 356
Self-citationMolecular effects of dopamine on striatal-projection pathways
Gerfen, C. R. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00019-7 · Cited by 341
Self-citationGerfen, C., Keefe, K., & Gauda, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-08167.1995 · Cited by 283
Self-citationMoratalla, R., Elibol, B., Vallejo, M., & Graybiel, A. M. (1996) · Neuron · doi:10.1016/s0896-6273(00)80288-3 · Cited by 276
Developmental Pathways to Substance Abuse
Mayes, L. C., & Suchman, N. E. (2015) · Developmental Psychopathology · doi:10.1002/9780470939406.ch16 · Cited by 54
Metadata
- Authors
- Steiner, H., & Gerfen, C. R.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 1995-03-06
- Volume
- 353
- Issue
- 2
- Pages
- 200-212
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2100781569
- Cited by
- 98
- References
- 6
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.